British American Tobacco (BAT) has again bet on the cannabis industry as it looks to diversify its portfolio as part of its plan to transition to a smoke-free future.

After increasing its stake in Canada’s CBD firm Organigram in April, the tobacco giant has now entered the European cannabis market, leading a $37.6m investment round into Germany’s medical cannabis business Sanity.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us